Delivery Order SPE2DB22D2005-SPE2DB24FJRC4

Award Date 8/9/24
Potential Completion Date 8/12/24
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,423.20, is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has a completion date of July 16, 2024 and is a firm fixed-price contract. AmerisourceBergen, a for-profit organization, is the prime contractor and there is no set-aside designation for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,534.21 fixed-price contract is for the supply of 4565220299 CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of July 23, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,613.58 firm-fixed-price contract is for the supply of 4565179136 CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The award has a completion date of July 18, 2024. This order is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the DLA to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $1,301.63 and a completion date of August 5, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to various...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,906.12, is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of July 16, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract is a firm fixed-price, indefinite delivery contract (IDC) with a ceiling value of $7,742.53 and a completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor and is not operating under a set-aside designation. The award is...
This is a $4,225.67 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $43,778.54 firm-fixed-price contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has an ultimate completion date of August 6, 2024 and was awarded on August 5, 2024. This contract is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $4,361.10. The contract has an ultimate completion date of November 3, 2023 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a ceiling value of $6,472.77 and a completion date of August 30, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medications and medical supplies to military treatment...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJRC4
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract, valued at $7,274.32, is for the supply of 4565404284 CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with an ultimate completion date of August 12, 2024. The contract is a firm fixed-price arrangement. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various agencies and healthcare programs. This award is not associated with a set-aside program.

Generated 11/8/24, 9:26 AM